The Gross Margin of ARS Pharmaceuticals Inc (SPRY) is 76.72%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-12-31 | 76.72% |
| 2024-12-31 | 99.02% |